BPG is committed to discovery and dissemination of knowledge
Retrospective Study
Copyright: ©Author(s) 2026.
World J Gastrointest Surg. Aug 27, 2026; 18(8): 118525
Published online Aug 27, 2026. doi: 10.4240/wjgs.118525
Table 1 Baseline characteristics of study participants, n (%)/mean ± SD
Characteristic
Observation group (n = 52)
Control group (n = 48)
Age (years)58.3 ± 10.559.7 ± 11.2
Male sex33 (63.5)29 (60.4)
BMI (kg/m2)23.8 ± 3.224.1 ± 3.5
Tumor distance from anal verge (cm)3.8 ± 1.23.6 ± 1.3
TNM stage
I12 (23.1)10 (20.8)
II21 (40.4)19 (39.6)
III19 (36.5)19 (39.6)
Neoadjuvant therapy35 (67.3)31 (64.6)
Time to stoma closure (months)4.2 ± 1.14.5 ± 1.3
Table 2 Anorectal manometry parameters over time, mean ± SD
Parameter
Time point
Observation (n = 52)
Control (n = 48)
RAP (mmHg)Baseline48.5 ± 10.347.2 ± 11.1
3 months65.3 ± 8.7c52.4 ± 9.2
6 months72.5 ± 7.8c58.3 ± 8.5
MSP (mmHg)Baseline85.3 ± 18.583.7 ± 19.2
3 months128.5 ± 15.3c98.7 ± 16.8
6 months145.2 ± 14.5c112.3 ± 17.2
Table 3 Functional outcomes and quality of life measures at 6 months, n (%)/mean ± SD
Outcome measure
Observation (n = 52)
Control (n = 48)
Wexner incontinence score4.2 ± 1.8c8.5 ± 2.3
Good continence (score ≤ 7)38 (73.1)b20 (41.7)
Time to normal defecation (days)68.5 ± 12.3c95.8 ± 18.5
Daily bowel frequency (times/day)3.8 ± 1.2c6.5 ± 2.1
Urgency10 (19.2)c25 (52.1)
FIQL total score (range 1-5)4.1 ± 0.6c3.2 ± 0.8
Patient satisfaction score (0-10)8.3 ± 1.1c6.1 ± 1.6
Table 4 Multivariate analysis of predictors for good continence at 6 months
Variable
Adjusted OR
95%CI
P value
Pelvic floor rehabilitation8.733.15-24.18< 0.001
Baseline MSP (per mmHg)1.051.02-1.080.002
Tumor distance from anal verge (per cm)1.421.08-1.870.012
Age (per year)0.970.93-1.010.156
Male sex1.230.48-3.150.665
Neoadjuvant therapy0.780.29-2.080.619


Write to the Help Desk